Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for BIO. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: BIO is a Sell candidate.
BIO price ended at $0.021369 on Friday, after rising 1.73%
On Mar 13, 2026 00:00, the price of BIO rose by 1.73%, climbing from $0.021120 to $0.021369 with 24h trading volume reaching $20.8M BIO.
BIO Technical Signals
Technical Signals Summary
Buy Signals 1
Neutral Signals 2
Sell Signals 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
BIO currently exhibits 1 buy signals and 4 sell signals. The token has been in an uptrend since 12:00 AM, with a total price change of 3.19% during this period. Overall, the technical indicators point to a Sell outlook for the mid-term.
Bullish/Bearish Signals for BIO
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for BIO. These insights help you make informed investment decisions.
Follow-Up Questions
Based on technical analysis, should I buy BIO?
BIO currently exhibits 1 buy signals and 4 sell signals. The stock has been in an downtrend since Mar 09, 2026, with a total price change of 3.19% during this period. Overall, the technical indicators point to a Sell outlook for the mid-term.
What is RSI of Bio Protocol (BIO)?
The RSI of Bio Protocol is 43.75, indicating neutral conditions.
Bio Protocol (BIO) MACD
Bio Protocol MACD is -0.002107
360Report
Key Stats
Trading Volume (24hr)
$20.8M
Circulating Supply
1.7B
Market Cap
$37.8M
Total Supply
3.3B
Holders
--
Max Supply
3.3B
FDV
$70.9M
Funding Rate
0.005%
Date of Creation
--
What is Bio Protocol (BIO)?
BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).
The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.
The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.